Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 553 insiders at 344 companies
- $9.7B sold by 664 insiders outside a trading plan
- $4.6B sold by 964 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Joseph Baratta DirectorBXBlackstone Inc.Sale$12.4M 100,000 shares at $123.80 12% of stakeTraded Sep 18 Filed Sep 18
-
Anthony Mathew Eisen DirectorXYZBlock, Inc.Planned sale$1.4M 18,000 shares at $77.63 1.3% of stakeTraded Sep 16–18 Filed Sep 18
-
Michael Schmertzler DirectorPTCTPTC Therapeutics, Inc.Planned sale$1.3M 20,000 shares at $67.49 1.5% of stakeTraded Sep 16–17 Filed Sep 18
-
Colette Kress CFONVDANvidia Corporation ComPlanned sale$7.6M 34,918 shares at $219.05 4.4% of stakeTraded Sep 17 Filed Sep 18
-
Yuen Wupen President, Global Bus. UnitsLITELumentum Holdings Inc.Planned sale$1.4M 1,500 shares at $903.43 1.3% of stakeTraded Sep 16–18 Filed Sep 18
-
Kumar Budur Chief Medical OfficerHRMYHarmony Biosciences Holdings, Inc.Planned sale$1.7M 38,452 shares at $43.05 75% of stakeTraded Sep 16–18 Filed Sep 18
-
Masatoshi Koide Pres. and Rep. Director, ALIJAFLAflac IncorporatedSale$1.6M 13,201 shares at $118.01 15% of stakeTraded Sep 16 Filed Sep 18
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.2M 64,000 shares at $97.49 12% of stakeTraded Sep 17–18 Filed Sep 18
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $496.06 2.8% of stakeTraded Sep 17 Filed Sep 18
-
John R. Furner CEOWMTWalmart Inc.Planned sale$1.4M 13,125 shares at $106.66 2% of stakeTraded Sep 17 Filed Sep 18
-
Paul A Mahon EVP & General CounselUTHRUnited Therapeutics CorporationPlanned sale$4.1M 8,300 shares at $497.54 16% of stakeTraded Sep 17 Filed Sep 18
-
Edward Carr Chief Accounting OfficerDNTHDianthus Therapeutics, Inc.Planned sale$2M 20,000 shares at $101.38 100% of stakeTraded Sep 17 Filed Sep 18
-
Sl Spv-2, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$26.7M 46,994 shares at $567.88 34% of stakeTraded Sep 16 Filed Sep 18
-
Silver Lake Partners IV, L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$32.3M 56,794 shares at $567.89Traded Sep 16 Filed Sep 18
-
George Raymond Zage III DirectorGRNDGrindr Inc.Planned sale$7.8M 500,000 shares at $15.55 6.2% of stakeTraded Sep 16–17 Filed Sep 18
-
Silver Lake Partners V DE (AIV), L.P. Director · +4 joint filersDELLDell Technologies Inc.Sale$15.3M 26,985 shares at $567.88 36% of stakeTraded Sep 16 Filed Sep 18
-
Richard M Schulze InsiderBBYBest Buy Co., Inc.Sale$27.8M 300,000 shares at $92.51 100% of stakeTraded Sep 16 Filed Sep 18
-
David Fortunato CEOWLTHWealthfront CorporationPlanned sale$1M 100,000 shares at $10.14Traded Sep 17 Filed Sep 18
-
Mauad Bruno Sousa DirectorAUGOAura Minerals Inc.Sale$6.8M 73,925 shares at $92.40 86% of stakeTraded Sep 17 Filed Sep 18
-
Lingke Wang PresidentLIFEEthos Technologies Inc.Planned sale$4.6M 118,333 shares at $38.96 7.1% of stakeTraded Sep 17 Filed Sep 18
-
Peter George Colis CEOLIFEEthos Technologies Inc.Planned sale$2.7M 70,000 shares at $38.51 4.4% of stakeTraded Sep 16–18 Filed Sep 18
-
Tajinder S Vohra Please See RemarksRVTYRevvity, Inc.Planned sale$1M 7,330 shares at $140.88 53% of stakeTraded Sep 16 Filed Sep 18
-
Robert L Bugbee PresidentSTNGScorpio Tankers Inc.Sale$22.2M 256,799 shares at $86.28 29% of stakeTraded Sep 16–17 Filed Sep 18
-
John R Buran DirectorOCFCOceanFirst Financial Corp.Sale$2.2M 113,630 shares at $19.40 100% of stakeTraded Aug 7 Filed Sep 18
-
Cameron Keyser Mackey COOSTNGScorpio Tankers Inc.Sale$11.1M 125,000 shares at $89.03 15% of stakeTraded Sep 17 Filed Sep 18
-
Christopher John Avella CFOSTNGScorpio Tankers Inc.Sale$4.9M 56,500 shares at $86.57 24% of stakeTraded Sep 16 Filed Sep 18
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.6M 13,800 shares at $117.49 <0.1% of stakeTraded Sep 16 Filed Sep 18
-
Jeffrey D Benjamin DirectorGOLDGold.com, Inc.Sale$1.1M 22,625 shares at $47.70 7% of stakeTraded Sep 16–17 Filed Sep 18
-
Bruno Constantino Alexandre Dos Santos DirectorXPXP Inc.Sale$2.4M 123,257 shares at $19.58 7.6% of stakeTraded Sep 16 Filed Sep 17
-
William E. Rote Chief Research OfficerTVTXTravere Therapeutics, Inc.Planned sale$13.1M 209,048 shares at $62.83 68% of stakeTraded Sep 15–16 Filed Sep 17
-
Jonathan Sheena FounderNTRANatera, Inc.Planned sale$3.2M 9,150 shares at $351.49 4% of stakeTraded Sep 15–16 Filed Sep 17
-
Peter Heerma EVP, Chief Commercial OfficerTVTXTravere Therapeutics, Inc.Planned sale$17.9M 283,189 shares at $63.06 71% of stakeTraded Sep 15–17 Filed Sep 17
-
Jula Inrig EVP, Head of R&D & CMOTVTXTravere Therapeutics, Inc.Planned sale$2.8M 44,674 shares at $62.34 31% of stakeTraded Sep 15 Filed Sep 17
-
Elizabeth E Reed Chief Legal Officer and GCTVTXTravere Therapeutics, Inc.Planned sale$2.3M 37,500 shares at $62.34 26% of stakeTraded Sep 15 Filed Sep 17
-
Eric M Dube CEOTVTXTravere Therapeutics, Inc.Planned sale$25.4M 400,000 shares at $63.48 48% of stakeTraded Sep 15–17 Filed Sep 17
-
Christopher R. Cline CFOTVTXTravere Therapeutics, Inc.Planned sale$3.1M 50,508 shares at $62.34 37% of stakeTraded Sep 15 Filed Sep 17
-
Kiran Kumar Choudary CFORBRKRubrik, Inc.Planned sale$1M 10,000 shares at $104.81 1% of stakeTraded Sep 15–17 Filed Sep 17
-
Jeffrey M Thompson CEORCATRed Cat Holdings, Inc.Planned sale$1.2M 150,000 shares at $7.74 1.3% of stakeTraded Sep 15 Filed Sep 17
-
Alexander D. Moore DirectorPLTRPalantir Technologies Inc.Planned sale$2.8M 16,000 shares at $172.64 1.5% of stakeTraded Sep 15 Filed Sep 17
-
Michael D. Sicilia CEOORCLOracle CorporationPlanned sale$1.5M 10,882 shares at $139.94 6.8% of stakeTraded Sep 16 Filed Sep 17
-
Rukmini Sivaraman CFONTNXNutanix, Inc.Planned sale$2.7M 38,139 shares at $70.00 11% of stakeTraded Sep 17 Filed Sep 17
-
Gerhard Watzinger DirectorCRWDCrowdStrike Holdings, Inc.Planned sale$28.6M 120,000 shares at $238.58 93% of stakeTraded Sep 16 Filed Sep 17
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$4.8M 20,000 shares at $242.47 0.3% of stakeTraded Sep 15–16 Filed Sep 17
-
Mark Locke CEOGENIGenius Sports LimitedSale$5.3M 800,000 shares at $6.57 4% of stakeTraded Sep 15–17 Filed Sep 17
-
Michael N Intrator CEOCRWVCoreWeave, Inc.Planned sale$25.2M 307,692 shares at $81.91Traded Sep 15 Filed Sep 17
-
Mike Slessor CEOFORMFormFactor, Inc.Planned sale$1.8M 17,510 shares at $104.73 3.6% of stakeTraded Sep 16 Filed Sep 17
-
Empresarial De Capitales S.a. De C.v. Control 10% ownerTALOTalos Energy, Inc.Sale$25.6M 1,381,000 shares at $18.52 3.4% of stakeTraded Sep 15 Filed Sep 17
-
Thomas M Siebel CEOAIC3.ai, Inc.Planned sale$4.8M 444,248 shares at $10.77 38% of stakeTraded Sep 15–16 Filed Sep 17
-
Christopher K Cox Chief Product OfficerMETAMeta Platforms, Inc., Class APlanned sale$13.5M 20,000 shares at $675.23 8.2% of stakeTraded Sep 15 Filed Sep 17
-
Kurt James Wolf CEOPBIPitney Bowes Inc.Planned sale$3.5M 199,258 shares at $17.34 66% of stakeTraded Sep 15–17 Filed Sep 17
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.